Artivion (AORT) vs Bioventus (BVS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Bioventus (BVS) has outperformed Artivion (AORT) over the past year, gaining 92.0% versus a loss of 46.7%. Over five years, AORT leads with a +1.2% price change compared with -6.4% for BVS. Artivion is the larger company by market cap ($1.05 billion vs $872.3 million), about 1.2 times the size.
On valuation, Bioventus trades at a lower forward P/E (13.9x vs 28.9x for Artivion).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AORT | BVS |
|---|---|---|
| Share price | $21.61 | $12.77 |
| Market cap | $1.05B | $872.26M |
| 1-day change | -1.05% | -2.52% |
| YTD return | -52.62% | +71.64% |
| 1-year return | -46.66% | +92.03% |
| 5-year return | +1.17% | -6.38% |
| P/E ratio (TTM) | — | 16.80 |
| Forward P/E | 28.88 | 13.88 |
| EPS (TTM) | $-0.07 | $0.76 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $48.25 | $15.89 |
| 52-week low | $19.16 | $6.37 |
| Distance from 52-week high | -55.21% | -19.65% |
| Average volume | 639.01K | 627.38K |
| Shares outstanding | 48.76M | 68.31M |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BVS has outperformed AORT by 138.7 percentage points over the past year.
AORT vs BVS FAQ
Which is bigger, Artivion or Bioventus?
Artivion (AORT) is larger, with a market capitalization of $1.05B compared with $872.26M for Bioventus (BVS).
Which stock has performed better over the past year, AORT or BVS?
BVS returned +92.03% over the past 12 months, compared with -46.66% for AORT (price return, excluding dividends). Past performance does not predict future results.
Are Artivion and Bioventus in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.